Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Plos Neglected Tropical Diseases|April 16, 2024
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platformSauman Singh-Phulgenda, Rishikesh Kumar, Prabin Dahal, et al.
The American Journal of Tropical Medicine and Hygiene|September 12, 2018
Noninvasive Sweat-Based Diagnosis of Visceral Leishmaniasis and Post Kala-Azar Dermal LeishmaniasisRoshan Kamal Topno, Vikas Shankar, Manas Ranjan Dikhit, et al.
Molecular Immunology|March 21, 2018
Immunomodulation induced through ornithine decarboxylase DNA immunization in Balb/c mice infected with Leishmania donovaniAkhilesh Kumar, Manas Ranjan Dikhit, Ajay Amit, et al.
The Journal of Antimicrobial Chemotherapy|May 10, 2024
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South AsiaSemra Palić, Wan-Yu Chu, Shyam Sundar, et al.
The Journal of Infectious Diseases|July 13, 2007
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasisSujit Kumar Bhattacharya, Prabhat Kumar Sinha, Shyam Sundar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 11, 2022
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 TrialSakib Burza, Raman Mahajan, Shahwar Kazmi, et al.
Lancet (London, England)|January 25, 2011
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trialShyam Sundar, Prabhat Kumar Sinha, Madhukar Rai, et al.
Plos Neglected Tropical Diseases|October 23, 2018
Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, IndiaVishal Goyal, Raman Mahajan, Krishna Pandey, et al.
Plos Neglected Tropical Diseases|June 20, 2024
A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and BangladeshShyam Sundar, Krishna Pandey, Dinesh Mondal, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 12, 2024
Insulator-to-Metal Transition and Isotropic Gigantic Magnetoresistance in Layered Magnetic SemiconductorsGokul Acharya, Bimal Neupane, Chia-Hsiu Hsu, et al.
Pageof 18